| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.54 | 0.009 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |